{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:37:44Z","timestamp":1790401064778,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11596-014-1224-1","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T02:52:06Z","timestamp":1391568726000},"page":"10-17","source":"Crossref","is-referenced-by-count":26,"title":["Advanced glycation end products promote differentiation of CD4+ T helper cells toward pro-inflammatory response"],"prefix":"10.1007","volume":"34","author":[{"given":"Xiao-qun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo-jiong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"issue":"1","key":"1224_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00003.2010","volume":"91","author":"B TL van","year":"2011","unstructured":"van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev, 2011,91(1):79\u2013118","journal-title":"Physiol Rev"},{"key":"1224_CR2","first-page":"42","volume":"771","author":"G E","year":"2012","unstructured":"Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol, 2012,771:42\u201350","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"1224_CR3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/gene.2011.14","volume":"12","author":"N BS","year":"2011","unstructured":"Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, et al. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun, 2011,12(4): 239\u2013250","journal-title":"Genes Immun"},{"issue":"2","key":"1224_CR4","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-12-0693","volume":"168","author":"C S","year":"2013","unstructured":"Culina S, Brezar V, Mallone R. Insulin and type 1 diabetes: immune connections. Eur J Endocrinol, 2013,168(2): R19\u2013R31","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1224_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/cr.2009.138","volume":"20","author":"Z J","year":"2010","unstructured":"Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res, 2010,20(1):4\u201312","journal-title":"Cell Res"},{"issue":"1","key":"1224_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-009-0187-y","volume":"32","author":"H K","year":"2010","unstructured":"Hirota K, Martin B, Veldhoen M. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol, 2010,32(1):3\u201316","journal-title":"Semin Immunopathol"},{"issue":"3","key":"1224_CR7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","volume":"38","author":"O N","year":"2013","unstructured":"Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity, 2013 38(3):414\u2013423","journal-title":"Immunity"},{"issue":"90","key":"1224_CR8","first-page":"175","volume":"2","author":"Z C","year":"2012","unstructured":"Zeng C, Shi X, Zhang B, et al. The imbalance of Th17\/Th1\/Treg in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med, 2012,2(90):175\u2013186","journal-title":"J Mol Med"},{"issue":"280","key":"1224_CR9","first-page":"16","volume":"1","author":"S S","year":"2012","unstructured":"Shao S, He F, Yang Y, et al. Th17 cells in type 1 diabetes. Cell Immun, 2012,1(280):16\u201321","journal-title":"Cell Immun"},{"issue":"3\u20134","key":"1224_CR10","first-page":"259","volume":"26","author":"G SE","year":"1999","unstructured":"Geerlings SE, Hoepelman AM. Immune dysfunction in patients with mellitus (DM). FEMS Immunol Med Microbiol, 1999,26(3\u20134):259\u2013265","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1224_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000324945","volume":"170","author":"T MC","year":"2011","unstructured":"Thomas MC. Advanced glycation end products. Contrib Nephrol, 2011,170:66\u201374","journal-title":"Contrib Nephrol"},{"issue":"6","key":"1224_CR12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"B M","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005,54(6):1615\u20131625","journal-title":"Diabetes"},{"issue":"8","key":"1224_CR13","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/j.1476-5381.2012.01910.x","volume":"166","author":"L J","year":"2012","unstructured":"Lin J, Tang Y, Kang Q, et al. Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPAR\u03b3 activity and attenuating oxidative stress. Br J Pharmacol, 2012,166(8): 2212\u20132227","journal-title":"Br J Pharmacol"},{"issue":"48","key":"1224_CR14","doi-asserted-by":"crossref","first-page":"47 376","DOI":"10.1074\/jbc.M301088200","volume":"278","author":"M C","year":"2003","unstructured":"Miele C, Riboulet A, Maitan MA, et al. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through protein kinase C alpha-mediated mechanism. J Biol Chem, 2003,278(48): 47 376\u201347 287","journal-title":"J Biol Chem"},{"issue":"6","key":"1224_CR15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ncb2062","volume":"12","author":"F S","year":"2010","unstructured":"Fraley S, Feng Y, Krishnamurthy R, et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat Cell Biol, 2010,12(6):598\u2013604","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1224_CR16","first-page":"650","volume":"29","author":"F S","year":"2011","unstructured":"Franke S, R\u00fcster C, Pester J, et al. Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol, 2011,29(4):650\u2013660","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"1224_CR17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00394-008-0753-4","volume":"48","author":"S T","year":"2009","unstructured":"Sato T, Wu X, Shimogaito N, et al. Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys. Eur J Nutr, 2009,48(1):6\u201311","journal-title":"Eur J Nutr"},{"issue":"6","key":"1224_CR18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","volume":"23","author":"P L","year":"2012","unstructured":"Poulsen L, Siersbaek M, Mandrup S. PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol, 2012,23(6):631\u2013639","journal-title":"Semin Cell Dev Biol"},{"issue":"5","key":"1224_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"A M","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, et al. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med, 2013,19(5):557\u2013566","journal-title":"Nat Med"},{"issue":"12","key":"1224_CR20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.bcp.2012.09.033","volume":"84","author":"M SK","year":"2012","unstructured":"Mahali SK, Manna SK. Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding. Biochem Pharmacol, 2012,84(12): 1681\u20131690","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1224_CR21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.toxlet.2011.07.026","volume":"206","author":"W SH","year":"2011","unstructured":"Wang SH, Guo YJ, Yuan Y, et al. PPAR\u03b3-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway. Toxicol Lett, 2011,206(3): 339\u2013346","journal-title":"Toxicol Lett"},{"issue":"2","key":"1224_CR22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2010.06.093","volume":"398","author":"M T","year":"2010","unstructured":"Matsui T, Yamagishi S, Takeuchi M, et al. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun, 2010,398(2):326\u2013330","journal-title":"Biochem Biophys Res Commun"},{"issue":"34","key":"1224_CR23","first-page":"583","volume":"12","author":"W M","year":"2013","unstructured":"W\u00e5llberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol, 2013,12(34):583\u2013591","journal-title":"Trends Immunol"},{"issue":"1","key":"1224_CR24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/imr.12032","volume":"252","author":"Y H","year":"2013","unstructured":"Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev, 2013,252(1):12\u201323","journal-title":"Immunol Rev"},{"issue":"6","key":"1224_CR25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3892\/ijmm.2012.1152","volume":"30","author":"K Y","year":"2012","unstructured":"Kitagishi Y, Kobayashi M, Yamashina Y, et al. Elucidating the regulation of T cell subsets (review). Int J Mol Med, 2012,30(6):1255\u20131260","journal-title":"Int J Mol Med"},{"issue":"6","key":"1224_CR26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.coi.2012.07.009","volume":"24","author":"W E","year":"2012","unstructured":"Wambre E, James EA, Kwok WW. Characterization of CD4+ T cell subsets in allergy. Curr Opin Immunol, 2012,24(6):700\u2013706","journal-title":"Curr Opin Immunol"},{"key":"1224_CR27","volume-title":"BioDrugs","author":"S I","year":"2013","unstructured":"Serr I, Weigmann B, Franke RK, et al. Treg vaccination in autoimmune type 1 diabetes. BioDrugs, 2013 [Epub ahead of print]"},{"issue":"4","key":"1224_CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11892-011-0198-7","volume":"11","author":"Z H","year":"2011","unstructured":"Zong H, Ward M, Stitt AW. AGEs, RAGE, and diabetic retinopathy. Curr Diab Rep, 2011,11(4):244\u2013252","journal-title":"Curr Diab Rep"},{"issue":"7404","key":"1224_CR29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"C D","year":"2012","unstructured":"Cipolletta D, Feuerer M, Li A, et al. PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature, 2012,486(7404):549\u2013553","journal-title":"Nature"},{"issue":"12","key":"1224_CR30","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1158\/0008-5472.CAN-12-4018","volume":"73","author":"B H","year":"2013","unstructured":"Berger H, V\u00e9gran F, Chikh M, et al. SOCS3 transactivation by PPAR\u03b3 prevents IL-17-driven cancer growth. Cancer Res, 2013,73(12):3578\u20133590","journal-title":"Cancer Res"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-014-1224-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-014-1224-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:42:33Z","timestamp":1565170953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-014-1224-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1007\/s11596-014-1224-1","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}